Rosuliv 20

Rosuliv 20 Tablet contains Rosuvastatin 20 mg, a high-potency statin (HMG-CoA reductase inhibitor) used for effective cholesterol management and cardiovascular risk reduction. Rosuvastatin works by inhibiting the enzyme responsible for cholesterol synthesis in the liver, leading to a significant reduction in low-density lipoprotein cholesterol (LDL-C), total cholesterol, and triglycerides, while modestly increasing high-density lipoprotein cholesterol (HDL-C). The 20 mg strength is considered a high-intensity statin dose, recommended for patients who require aggressive lipid-lowering therapy, such as those with established atherosclerotic cardiovascular disease or diabetes with multiple risk factors. Rosuliv 20 not only helps achieve target lipid levels but also plays a critical role in stabilizing atherosclerotic plaques and reducing inflammation within blood vessels, thereby lowering the risk of heart attack, stroke, and other cardiovascular complications. It is generally taken once daily, with or without food, and is known for its strong efficacy and favorable tolerability profile.

Rosuliv 20 is generally well tolerated, but some patients may experience side effects such as muscle pain, weakness, headache, nausea, abdominal discomfort, or constipation. Rarely, it may cause serious adverse effects such as myopathy, rhabdomyolysis, or elevated liver enzymes. Regular monitoring of liver function and creatine kinase levels may be recommended in long-term or high-dose therapy. Inform your doctor if you notice symptoms like unexplained muscle pain or yellowing of the eyes or skin.

Rosuliv 20 Tablet is indicated for the treatment of hyperlipidemia and mixed dyslipidemia, including familial and non-familial forms. It is also used for the primary and secondary prevention of cardiovascular events in high-risk individuals, such as those with coronary artery disease, diabetes, or a history of myocardial infarction or stroke.

Rosuliv 20 Tablet should only be used under medical supervision. It is contraindicated in patients with active liver disease, severe renal impairment, or known hypersensitivity to Rosuvastatin. Alcohol consumption should be limited during therapy to reduce the risk of liver damage. Use during pregnancy and breastfeeding is strictly contraindicated, as statins may harm fetal development. Patients should adhere to a cholesterol-lowering diet and lifestyle along with medication. Routine blood tests to monitor lipid levels and liver enzymes are advised to ensure treatment safety and efficacy.

Store Rosuliv 20 Tablet in a cool, dry place below 30°C. Protect from moisture, heat, and direct sunlight. Keep out of reach of children and do not use the medicine after the expiry date mentioned on the packaging.